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Objectives The aim of this study was to evaluate the impact of echocardiographic contrast utilization on patient diagnosis
and management.
Background Contrast echocardiography (CE) has improved visualization of endocardial borders. However, its impact on pa-
tient management has not been evaluated previously.
Methods We prospectively enrolled 632 consecutive patients with technically difficult echocardiographic studies who re-
ceived intravenous contrast (Definity, Lantheus Medical Imaging, Billerica, Massachusetts). Quality of studies,
number of left ventricular (LV) segments visualized, estimated ejection fraction, presence of apical thrombus,
and management decisions were compared before and after contrast.
Results After CE, the percent of uninterpretable studies decreased from 11.7% to 0.3% and technically difficult studies
decreased from 86.7% to 9.8% (p  0.0001). Before contrast, 11.6  3.3 of 17 LV segments were seen, which
improved after CE to 16.8  1.1 (p  0.0001). An LV thrombus was suspected in 35 patients and was definite
in 3 patients before CE. After contrast, only 1 patient had a suspected thrombus, and 5 additional patients with
thrombus were identified (p  0.0001). A significant impact of CE on management was observed: additional
diagnostic procedures were avoided in 32.8% of patients and drug management was altered in 10.4%, with a
total impact (procedures avoided, change in drugs, or both) observed in 35.6% of patients. The impact of con-
trast increased with worsening quality of nonenhanced study, the highest being in intensive care units. A cost–
benefit analysis showed a significant savings using contrast ($122/patient).
Conclusions The utilization of CE in technically difficult cases improves endocardial visualization and impacts cardiac diagno-
sis, resource utilization, and patient management. (J Am Coll Cardiol 2009;53:802–10) © 2009 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.01.005b
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rn the last decade, contrast echocardiography (CE) media
ave rapidly evolved and are now widely used clinically to
ptimize ultrasound image quality. Several studies have
hown that CE improves the assessment of global and
egional left ventricular (LV) function, enhances the detec-
ion of LV thrombi, and decreases variability of interpreta-
ion (1–13). It has been estimated that 10% to 15% of
outine echocardiograms have incomplete endocardial reso-
ution, reaching 25% to 30% in critically ill patients in the
ntensive care unit (ICU) (14).
rom the Department of Cardiology, The Methodist Hospital, and The Methodist
eBakey Heart and Vascular Center Imaging Institute, Houston, Texas. This study
as presented in part at the 57th Annual Scientific Sessions of the American College
f Cardiology, March 31, 2008, Chicago, Illinois.t
Manuscript received September 18, 2008; revised manuscript received January 6,
009, accepted January 12, 2009.Although there is a wealth of information regarding the
enefit of CE with regard to improving image quality and
ssessment of LV function, there are limited published data
egarding the impact of contrast agents on patient manage-
ent. The present study was therefore designed to prospec-
ively evaluate the impact of contrast use on cardiac diag-
osis and management compared with noncontrast studies
n a large cohort of consecutive patients who have under-
one both unenhanced and contrast-enhanced echocardio-
rams as part of routine care.
ethods
atient population. We prospectively enrolled consecutive
atients with technically difficult studies who underwent a
est echocardiogram and received echocardiographic con-
rast for image enhancement at the Methodist DeBakey
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March 3, 2009:802–10 Diagnostic Impact of Contrast Echocardiographyeart and Vascular Center from June 2007 to October
007. The stop date represented the release of the Federal
rug Administration warning on the use of echocardio-
raphic contrast (15). The study was approved by the
nstitutional Review Board of the Methodist Hospital
esearch Institute. A total of 65 primary physicians were
nvolved in the care of the cohort of patients, and all
hysicians gave permission to review their patients’ medical
ecords. All patients who had received contrast during
outine echocardiograms in the time frame of this study
ere included, with no patient drop-out. Studies on myo-
ardial perfusion and stress echocardiography with contrast
re not included in this report.
nenhanced and contrast-enhanced echocardiographic
tudies. Before performing the echocardiography study,
aseline clinical characteristics were recorded. A complete
-dimensional and Doppler echocardiographic study was
hen performed using standardized protocols from the
arasternal and apical windows (Sonos 5500/7500, Philips
edical Systems, Bothell, Washington; and Vivid 7, Gen-
ral Electric Medical Systems, Milwaukee, Wisconsin).
aseline images were obtained using second harmonic
maging and high mechanical index (1.0 to 1.5), with other
ettings tailored to optimize image quality.
If the echocardiography study was deemed technically
ifficult by the sonographer, contrast was given according to
he American Society of Echocardiography guidelines
16,17). The contrast agent used was Definity (Lantheus
edical Imaging, Billerica, Massachusetts) as follows: 1.5
l of activated Definity was diluted in 8.5 ml of saline (total
olution of 10 ml), and administered in 1- to 2-ml boluses
ollowed by a saline flush as needed to optimize image
uality. The CE images were obtained using a mechanical
ndex between 0.3 and 0.5. The contrast images were
ppended at the end of the noncontrast study, and all
mages were stored on a central server and interpreted
ithin a few hours on an off-line workstation (Digiview 6.0,
igisonics, Houston, Texas).
mage interpretation. The noncontrast-enhanced images
ere interpreted first by one observer, followed by interpre-
ation of the contrast-enhanced images and full study by
nother independent observer. The observers who were the
ssigned readers on the day of the studies were from a pool
f 6 experienced echocardiographers. Both sets of images
ere interpreted independently by the 2 observers with
pecial attention to: 1) the number of LV segments visual-
zed (normal vs. abnormal wall motion); 2) estimating left
entricular ejection fraction (LVEF); 3) the suspicion or
resence of an LV thrombus; and 4) image quality. Image
uality was scored as: 1  adequate; 2  technically
ifficult; and 3  uninterpretable. A technically difficult
tudy was defined as a study in which 2 myocardial
egments were not visualized at baseline from any imaging
indow. An uninterpretable study was defined as a study in
hich 50% of the endocardium was not visualized fromny window and no reliable information regarding LVEF aould be reported. The LVEF
as estimated, when feasible, in
ncremental ranges of 5% (e.g.,
5% to 39%, 40% to 45%, and so
n) between 20% and 70%, and
s 20% and 70% when it
xceeded this range. Regional
V function was assessed using
he 17-segment model (16). The
umber of segments with normal
nd abnormal wall motion ade-
uately visualized was noted. An
ssessment of presence, absence,
r suspicion of apical thrombus
as also determined.
ssessment of impact of contrast
n clinical management. After
he separate interpretations of the noncontrast and full study
ith contrast were performed, the 2 interpretations were
ompared. Immediately afterward, and before electronically
nalizing the report, the primary physician was contacted and
iven the echocardiographic results without contrast, and was
sked about his or her management plan. Specifically, each
hysician was asked a set of questions by the same individual
M.K.) regarding whether he or she planned to order any more
ardiac diagnostic tests (e.g., transesophageal echocardiography
TEE], radionuclide ventriculogram, stress testing, or coronary
ngiography) and/or alter the patient’s cardiovascular medica-
ion regimen. The results of CE images were then revealed and
he primary physician was then asked by the same individual
M.K.) how these results would alter the initial management
lan, if any. Cardiovascular management impact focused on
nitiation or discontinuation of hemodynamically active drugs
diuretics, intravenous fluids, inotropic agents, vasodilators,
nd so on), anticoagulation therapy, and/or the need for further
iagnostic studies such as TEE, radionuclide imaging, stress
esting, or coronary angiography. The management plan iden-
ified was checked with the subsequent hospital record. If other
ests were performed, the results of ventricular function were
ompared with those of the echocardiographic study.
The above protocol approach and timing of the contact
ith the referring physician was done so that: 1) the
eferring physician had no access to the final report and
iagnosis before we asked about impact on management; 2)
ach patient could serve as his/her own control, thus
llowing evaluation of contrast impact; and 3) this approach
id not hinder routine patient care because the final report
as available soon after contact with the physician was
stablished.
ssessment of safety. The contrast study, although pro-
pective, did not include a prospective assessment of safety,
ecause it was initiated and conducted before the U.S. Food
nd Drug Administration warning. To assess safety of
ontrast in this population, which included many patients
ith later contraindications to contrast use by the U.S. Food
Abbreviations
and Acronyms
CE  contrast
echocardiography
ICU  intensive care unit
LV  left
ventricle/ventricular
LVEF  left ventricular
ejection fraction
MICU  medical intensive
care unit
SICU  surgical intensive
care unit
TEE  transesophageal
echocardiogram/
echocardiographynd Drug Administration (the majority were changed sub-
s
r
t
s
o
a
i
a
C
m
M
2
t
$
$
a
a
d
w
F
f
p
S
v
v
M
d
(
a
t
a
s
(
m
M
u
a
o
t
p
d
a
s
f
n
c

804 Kurt et al. JACC Vol. 53, No. 9, 2009
Diagnostic Impact of Contrast Echocardiography March 3, 2009:802–10equently to warnings), electronic hospital records were
eviewed for all inpatients and a telephone call was given for
he outpatients. The safety end points sought were any
ignificant hypotension noted in the nurses’ notes, the
ccurrence of an anaphylactoid reaction, new chest pain,
cute myocardial infarction, cardiac arrhythmia requiring
ntervention, cardiac arrest, or death within the ensuing 24 h
fter contrast administration.
ost– benefit and resource utilization patterns. For esti-
ating the economic impact, the national average of the
edicare-allowable charges for cardiovascular testing for
008 was used. Using the Medicare fee schedule (18), the
otal median global charges reimbursed by Medicare were:
62.00 for echocardiographic contrast, $490.18 for a TEE,
426.30 for a resting radionuclide-gated ventriculogram,
nd $847.20 for a radionuclide stress test. A cost–benefit
nalysis was performed using the cost of using echocar-
iographic contrast over the cost of procedures that
ould have been performed, had contrast not been used.
urthermore, a cost-effectiveness analysis also was per-
ormed using the cost of contrast over the number of
rocedures avoided.
tatistical analysis. Summary statistics for demographic
ariables are presented as mean  SD for continuous
Before Contrast
0.0%
20.0%
40.0%
60.0%
80.0%
100.0%
Adequate 1.4% 1.3% 0.0% 4.6% 1.6%
Technically
Difficult
88.8% 93.6% 74.5% 86.2% 86.7%
Uninterpretable 9.9% 5.1% 25.5% 9.2% 11.7%
Inpt 
Wards
MICU SICU
Out 
patient
Total
                    n=365     n=78     n=102      n=87     n=632       
Figure 1 Impact of Contrast on Quality of Study
A significant increase in quality of echocardiograms is seen after contrast use acr
before and after contrast for total and all subgroups. Inpt  inpatient; MICU  meariables and count (%) for categorical variables. Separate
cNemar tests were used to determine significantly
ifferent pre- and post-contrast proportions of subjects
summed over subgroups by locations) with uninterpret-
ble and adequate scans (Fig. 1). Wilcoxon signed rank
ests were used to test for significant differences in
verages of pre- and post-contrast per-subject visualized
egments and per-subject abnormal visualized segments
Fig. 2). We also tested the effects of contrast enhance-
ent on detection of LV thrombi, for which we used the
cNemar test.
Separate 1-sample tests of proportions (Ho: p  0) were
sed for determining whether the fraction of patients having
positive impact for procedural change, medication change,
r both was significantly different from zero. Two-sample
ests of proportions were used to determine whether the
roportion of patients having a positive impact (for proce-
ural change, medication change, or both) were different
cross patient subgroups. Contingency table analysis (chi-
quare test) was used for testing heterogeneity among
requencies of positive impact (yes/no) versus frequency of
onvisualized segments before contrast partitioned into
ategories based on the cut points 0 to 1, 2 to 6, 7 to 11, and
12 segments.
After Contrast
0.0%
20.0%
40.0%
60.0%
80.0%
100.0%
Adequate* 90.1% 96.2% 78.4% 96.6% 89.9%
Technically difficult* 9.6% 3.8% 21.6% 3.4% 9.8%
Uniterpretable* 0.3% 0.0% 1.0% 0.0% 0.3%
Inpt 
Wards
MICU SICU
Out 
patient
Total
n=365 n=78 n=102 n=87 n=632
locations. *p  0.0001 comparing quality
ntensive care unit; SICU  surgical intensive care unit.oss all
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atient characteristics. A total of 632 consecutive patients
ith technically difficult studies who underwent CE for
ndocardial enhancement constituted the study population.
o patients were excluded from analysis. All management
ecisions conformed to the response of the physicians and
ere verified by chart review. The cohort comprised 14.5%
f the total routine transthoracic echocardiograms per-
ormed during the study period (4,362 total studies). Con-
Total Visualized Segments
11.8
16.8
11.8
17
9.7
16.5
12.9
17
11.5
16.8
0
2
4
6
8
10
12
14
16
18
Inpatient
Wards
MICU SICU Out-
patient
Total
n = 632
Average number of visualized segments before CE
Average number of visualized segments after CE
** ** *
Figure 2 Impact of Contrast on Segments Visualized Per Patien
After contrast, a significant increase in visualization of total number of segments a
ments visualized before and after contrast. †p  0.0016 comparing number of se
abbreviations as in Figure 1.
atient Characteristics
Table 1 Patient Characteristics
Parameter Value
N 632
Age (yrs) 63.6 14
Male 396 (62.7%)
Body surface area (m2) 2.09 0.28
Past medical history
Hypertension 416 (65.8%)
Diabetes mellitus 192 (30.4%)
Coronary artery disease 243 (38.4%)
Chronic obstructive pulmonary disease 72 (11.4%)
Location
Inpatients 545 (86.2%)
Wards 365 (57.8%)
Surgical intensive care units 102 (16.1%)
Medical intensive care units 78 (12.3%)
Outpatients 87 (13.8%)ata are reported as mean  SD or n (%).rast utilization was 19% in all inpatients (545 of 2,857
xaminations), with 18.2% in the inpatient wards (365 of
,005 examinations) and 21.1% in the ICUs (180 of 852
xaminations), and 5.8% in outpatients (87 of 1,505 of
xaminations).
Baseline patient characteristics are listed in Table 1. The
ajority of patients were inpatients (86.2%), with 28.4%
esiding in the ICUs (180 of 632 of examinations). The
linical indications for the echocardiographic studies that
equired contrast are shown in Table 2. The majority of
ndications were for heart failure and for evaluation of chest
ain, coronary artery disease, or acute coronary syndromes,
ollectively accounting for 362 (59%) of the total studies.
mpact of contrast on the overall quality of the echocar-
iographic studies. Before CE, 548 studies (86.7%) were
echnically difficult and a total of 74 studies (11.7%) were
Abnormal Visualized Segments
2.3
3.4
4.1
6.2
3.1
5.3
1.5
2
2.5
3.9
1
2
3
4
5
6
7
8
Inpatient
Wards
MICU SICU Out -
patient
Total
n = 632
Average number of abnormal segments before CE
Average number of abnormal segments after CE
*
*
*
*
†
abnormal segments was observed. *p  0.0001 comparing number of seg-
s visualized before and after contrast. CE  contrast echocardiography; other
ndications for Rest Echocardiogramsho Required Contrast Enhancement
Table 2 Indications for Rest EchocardiogramsWho Required Contrast Enhancement
Clinical Indication n (%)
Congestive heart failure 190 (30.1)
Chest pain/acute coronary syndrome 111 (17.6)
Coronary artery disease 71 (11.2)
Valvular assessment 61 (9.7)
Hypertension 57 (9)
Pericardial effusion 28 (4.4)
Stroke 27 (4.3)
Other 87 (13.7)t
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Diagnostic Impact of Contrast Echocardiography March 3, 2009:802–10eemed uninterpretable (Fig. 1). After review by the ob-
ervers, 10 studies (1.6%) were considered adequate before
ontrast to make a reliable assessment of LV function. The
argest group of uninterpretable studies was seen in the
urgical intensive care unit (SICU), comprising almost 26%
f that group. After CE, the percent of uninterpretable
tudies decreased from 11.7% to 0.3% and technically
ifficult studies decreased from 86.7% to 9.8%, with a
esultant increase in adequate studies from 1.6% to 89.9%
McNemar, all p  0.0001). The greatest degree of im-
rovement in quality was seen in the SICU cohort. Thus,
verall, there was a salvage of 558 studies (88.3%) from
echnically difficult or uninterpretable studies to adequate
tudies.
ffect of contrast on interpretation of regional and global
entricular function. The total number of segments visu-
lized before contrast was 7,358 segments, equating to an
verage of 11.6 segments per patient or 68% of the LV
yocardium. The lowest average number of segments
isualized was seen in the SICU and the highest in the
utpatient group (Fig. 2). After contrast administration, the
otal number of segments visualized increased to 10,617
egments, equating to 16.8 segments per patient or 98.8% of
he LV myocardium (Wilcoxon, p  0.0001). Again, the
argest degree of improvement was seen in the SICU.
The effect of contrast on the extent of abnormal wall
otion is also shown in Figure 2. The total number of
bnormal segments visualized increased after CE from 2.54
4.8 segments to 3.87  6.5 segments (Wilcoxon, p 
.0001). This increase was seen in all patient subgroups, but
as most pronounced in the ICUs, where patients also had
he greatest extent of wall motion abnormality (Wilcoxon,
 0.0001) (Fig. 2). New wall motion abnormalities
isualized after CE, and not present on the unenhanced
tudy were detected in 156 patients (28% of studies),
xcluding studies initially classified as uninterpretable
Ho: p  0, p  0.0001). Conversely, wall motion
65.20%
9.80%
13.30%
11.70%
73.90%
14.90%
10.90%
0.30%
Before Contrast After Contrast
EF >50% EF 30-50% EF <30% Uninterpretable
Figure 3 Impact of Contrast on Left Ventricular EF Assessment
After contrast, a significant decrease in the number of uninterpretable
studies was seen, with overall higher left ventricular ejection fraction (EF).(bnormality interpreted in the unenhanced study that no
onger was present after contrast was seen in 5 patients
0.9% of studies).
The addition of contrast also had a significant effect on
he assessment of LVEF (Fig. 3). Interpretation of CE
mages produced a change in ejection fraction (defined as
n absolute difference between interpretations of 10%
ased on previous studies of reproducibility), in a total of
3 (16.7%) patients. The vast majority of these were
nderestimations of LVEF on the unenhanced contrast
mages (88 studies or 94.5%). If uninterpretable studies
ere also included, the SICU had the greatest portion of
atients with a change in LVEF after CE (36 patients or
5.3%) and the outpatient group had the lowest (12
atients or 13.7%).
ffect of contrast on diagnosis of LV thrombus. Before
ontrast administration, 35 patients were suspected to have
n apical thrombus, whereas 3 patients were thought to
efinitely have a thrombus. After contrast enhancement, an
pical thrombus was diagnosed in 5 more patients and
xcluded in all others except 1 patient in whom thrombus was
till suspected but could not be confirmed. Thus, the number
f suspected thrombi decreased from 35 patients to only 1
atient after contrast utilization (McNemar, p  0.0001).
mpact of contrast on patient management. DIAGNOSTIC
ROCEDURES. Based on the response of the treating physi-
ians, contrast led to avoidance of further diagnostic proce-
ures in 207 patients (32.8%) because of improved assess-
ent of LV function (Ho: p  0, p  0.0001) (Fig. 4). The
voided procedures were either a TEE (67 patients, 32.4%)
r a nuclear imaging study (140 patients or 67.7%: resting
ated studies in 84 and stress nuclear in 56), both of which
ere originally planned to better assess LV function. A total
f 56 patients (55%) in the SICU group had a procedure
voided, whereas 114 patients (31%) and 26 patients (33%)
ad procedures avoided in the inpatient ward and medical
ntensive care unit (MICU) groups, respectively. The SICU
roup had a greater degree of procedures avoided relative to
he inpatient ward and outpatient groups (Ho: p1  p2, p 
.0001 for both).
From the cohort of 632 patients, 86 patients ultimately
nderwent coronary angiography, 36 had stress nuclear
maging, and 3 had CT angiography for evaluation of
oronary artery disease. All of these patients had the
dditional procedures to evaluate for ischemia or coronary
rtery disease based on an abnormal echocardiogram. Fifty-
ight of the 86 patients (67%) underwent the further testing
ecause of CE: images were previously uninterpretable and
ubsequently showed LV dysfunction (n  22 patients) or
ew wall motion abnormalities were noted (n  36 pa-
ients). The LVEF after CE was within 5% of LVEF by the
ther modalities in 113 of 125 patients (90.4%), within 10%
n 10 patients (8%), and discordant by 10% in 2 patients
1.6%).
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March 3, 2009:802–10 Diagnostic Impact of Contrast EchocardiographyRUG MANAGEMENT. The patients’ medical regimen was
ltered in 67 patients (10.6%) after interpretation of CE
mages (Ho: p  0, p  0.0001) (Fig. 5). Specifically, the
hange in medical regimen included the addition or discon-
inuation of hemodynamically active drugs (i.e., diuretics,
asopressors, inotropes, intravenous fluids, and vasodilators)
nd the addition or cessation of anticoagulation after con-
rmation or exclusion of an LV thrombus. Twenty-six
atients in the SICU (25.5%), 34 patients in inpatient wards
9.3%), and 7 patients in the MICU (8.9%) had such
edication changes. The largest impact was seen in the
ICU relative to the inpatient, MICU, and outpatient
roups (Ho: p1  p2, p  0.0001).
VERALL IMPACT. The total impact of contrast (change in
rugs, procedures, or both) was seen in 225 patients or
5.6% of suboptimal quality studies (Fig. 6). The highest
mpact by location of patients was seen in the SICU (n 
4; 62.7% of SICU contrast studies), followed by MICU
nd inpatient wards, and least in the outpatient setting (Ho:
 0, all p  0.0001) (Fig. 6). Importantly, the degree of
mpact was related to the extent of endocardial visualization
excluding patients with suspected thrombi): as the number
f nonvisualized segments increased, the degree of impact
ncreased, with the highest impact of 93.6% seen in patients
ith 12 nonvisualized segments on unenhanced images
chi-square, p  0.0005) (Fig. 7).
ost benefit and cost-effectiveness analysis. According to
he Medicare fee schedule for 2008, the total charges of
ontrast administration for the entire cohort of 632 patients
as $39,184. The total cost of the diagnostic procedures
5.50%
25.80%
68.70%
16.70%
16.70%
66.60%
31.40%
23.50%
45.10%
2.30%
10.30%
87.40%
Inpatient Wards 
n=365
       MICU       
n=78
         SICU        
n=102
     Outpatient     
n=87
TEE Avoided Nuclear Imaging Avoided No Procedure Change
*†
Figure 4 Impact of Contrast on
Additional Planned Diagnostic Procedures
The use of contrast avoided further planned diagnostic procedures, the
highest observed in the SICU setting. *p  0.0001 comparing SICU with inpa-
tients. †p  0.0001 comparing SICU with outpatients. TEE  transesophageal
echocardiogram; other abbreviations as in Figure 1.hat were avoided (both TEE and nuclear testing) in theohort was $116,094. Thus a savings of $76,910 in the 632
atients was realized with utilization of contrast, with an
verage savings or diagnostic cost–benefit of $122 per
atient. When evaluating diagnostic cost effectiveness, a
otal of 207 procedures were avoided; thus, $189 was spent
o avoid 1 additional diagnostic procedure of TEE or
uclear testing.
afety. Of the 545 hospitalized inpatients and 87 outpa-
ients, 5 complained of back pain after contrast administra-
ion. There were no anaphylactoid reactions, hypotension,
hest pain, acute myocardial infarction, or significant re-
orted arrhythmias requiring intervention in the ensuing
4 h. There was 1 death in a 78-year-old patient who had
large acute myocardial infarction after knee replacement,
evere hypotension, and recurrent ventricular tachycardia
ithin the 24 h before the echocardiographic study. Con-
rast echocardiography to evaluate ventricular function
howed severe LV dysfunction. After contrast administra-
ion, there was no change in the patient’s vital signs or
lectrocardiogram. He died 5 h later of continued severe
eart failure.
iscussion
he present investigation shows that, in addition to im-
roving overall study quality and LV function assessment,
ontrast enhancement results in a significant impact on
atient management. This was evident in both the reduc-
ion in the number of additional diagnostic procedures and
n the significant alteration in medical management. The
mpact of contrast enhancement is inversely related to the
85.30%
5.90%
8.80%
57.10%
14.30%
14.30%
77.00%
19.20%
3.80%
Inpatient Wards  
n=34
              MICU          
n=7
               SICU           
n=26
Hemodynamic Drug Started Hemodynamic Drug Stopped
Anticoagulation Started Anticoagulation Stopped
*†
14.30% 
Figure 5 Impact of Contrast on Medication Changes
Frequency of changes in hemodynamic drugs and anticoagulation
observed by patient location. *p  0.0001 comparing SICU with inpatients.
†p  0.0001 comparing SICU with MICU. Abbreviations as in Figure 1.
q
m
I
f
c
a
t
a
u
w
d
s
a
s
F
1
s
d
c
(
t
c
c
o
u
t
c
b
s
I
v
m
(
i
s
t
808 Kurt et al. JACC Vol. 53, No. 9, 2009
Diagnostic Impact of Contrast Echocardiography March 3, 2009:802–10uality of the unenhanced echocardiographic study and is
ost pronounced in critically ill and hospitalized patients.
mpact of contrast on study quality and evaluation of LV
unction. Several studies have shown that the use of
ontrast improves image quality and allows for a more
ccurate assessment of LV volumes and ejection fraction,
hrombus detection, and a decrease in both intraobserver
24.10%
1.40%
7.90%
66.60%
28.20%
2.60%
5.10%
64.10%
Inpatient
Wards
MICU
Procedure Avoided, only
Both Medication and Procedural Cha
n=365 n=78
Figure 6 Total Impact of Contrast on Patient Management
Frequency of total impact of contrast use on patient management. The highest im
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urthermore, 16.7% of patients had a change of more than
0% in LVEF after contrast enhancement. The present
tudy corroborates these findings, showing a significant
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ontrast utilization. There was a salvage of 558 studies
88.3%) from technically difficult or uninterpretable studies
o adequate studies. Our data also showed a significant
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f new wall motion abnormalities previously unseen on
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aseline, that is, the critically ill patients, particularly after
urgery.
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March 3, 2009:802–10 Diagnostic Impact of Contrast Echocardiographyn patients with resting echocardiograms used in the routine
linical setting. Similar to Thanigaraj et al. (19), there were
o additional procedures ordered to evaluate LV function or
egmental wall analysis after contrast enhancement. In
ddition to avoidance of additional diagnostic procedures
uch as TEE or radionuclide testing in 32.4% of patients,
he impact of contrast also was seen in 10.4% of patients
ith regard to altering cardiovascular drug regimens, in-
luding alteration of anticoagulation in patients with sus-
ected apical thrombus. Thus, a total of 35.6% of patients
eceiving contrast for technically difficult studies had a
ignificant impact on their clinical care, in terms of avoid-
nce of additional procedures, alteration of medical man-
gement, or both.
Patients who are difficult to image with echocardiography
re often referred for additional testing to obtain accurate
nformation. Although these modalities can provide accu-
ate information, they may be associated with additional
isks, time delays, and costs. Thus, in these technically
ifficult to image patients, a rapid, simple, inexpensive, and
afe test that results in accurate information is desirable.
ost-effective analysis of contrast use has been evaluated
reviously (19–21). We have previously shown the cost
ffectiveness of using contrast compared with TEE in select
atients referred for TEE because of technically very diffi-
ult studies in the ICU (13). Our current results on the
mpact of contrast on management in consecutive patients
equiring CE are concordant with prior data, showing a
avings of $122/patient. Importantly, this cost–benefit anal-
sis is conservative because it addresses downstream utiliza-
ion of diagnostic procedures alone and does not include the
otential effects of adjusting and correcting the initial
edical therapy on patient outcome.
mpact of contrast varies with baseline quality of
tudy. An interesting finding from this study is that the
mpact of contrast on patient management was inversely
elated to the quality of the baseline study. The greatest
egree of improvement in evaluation of LVEF and regional
unction was seen in the ICU population, especially in the
ICU. This same group also had the highest impact of CE
n management (62.7%). This finding is important because
t supports the use of contrast in patients whose baseline
tudy is suboptimal, using the standard American Society of
chocardiography definition of 2 nonvisualized myocar-
ial segments. Furthermore, it also underlines the impor-
ance of contrast use, particularly in hospitalized patients,
ecause the recent initial contraindications to use of contrast
utlined by the Federal Drug Administration excluded
atients with cardiovascular instability—essentially a major-
ty of patients in the ICUs—from receiving contrast for
ndocardial enhancement. On May 13, 2008, however,
hose contraindications were changed to warnings, as more
ata supporting the safety of CE surfaced (22). The current
tudy further supports the safety and the risk–benefit ratio
f contrast agents even in the critically ill setting, where theajority of contrast utilization in rest echocardiograms is
een.
tudy advantages and limitations. The study was per-
ormed with a relatively large group of consecutive patients
ith no patient dropout. In addition, each patient served as
heir own control, as all patients were evaluated both before
nd after contrast administration. The assessment of impact
as obtained immediately before releasing the pre- and
ost-contrast image results to the primary physician, and
hen reviewing the medical chart to confirm these findings.
ne limitation with the design of this study is a bias from
he primary physician. It is conceivable that a given physi-
ian may alter his or her responses to the question of patient
anagement the more times he or she were contacted. This
ias was unavoidable, but was thought to be small given the
arge number of physicians (n  65) involved in the cohort
ver an extended period of time.
onclusions
he utilization of CE in technically difficult patients sig-
ificantly improves endocardial visualization and impacts
ardiac diagnosis, resource utilization, and patient manage-
ent. The improvement in assessment of LV function and
mpact on management was more pronounced with increas-
ng technical difficulty of the studies, which was more often
een in hospitalized and critically ill patients.
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